Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Axim Biotechnologies (AXIM)

Axim Biotechnologies (AXIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4100 +14.63%
on 11/14/19
0.5900 -20.34%
on 10/21/19
-0.0250 (-5.05%)
since 10/14/19
3-Month
0.4100 +14.63%
on 11/14/19
0.8600 -45.35%
on 09/20/19
-0.1640 (-25.87%)
since 08/14/19
52-Week
0.4100 +14.63%
on 11/14/19
2.5000 -81.20%
on 02/08/19
-0.7300 (-60.83%)
since 11/14/18

Most Recent Stories

More News
AXIM(R) Biotechnologies Nutraceutical Division Announces Cannabinoid-Based Wellness Gum Product Line at Benzinga Cannabis Capital Conference

AXIMBiotechnologies, Inc. ("AXIM(R) Biotech," "AXIM" or "the Company") (OTCQB: AXIM), a world leader in cannabinoid research and development, announced today that its nutraceutical division, AXIM(R) Wellness,...

CBCA : 0.2000 (+100.00%)
AXIM : 0.4700 (-0.21%)
AXIM(R) Biotechnologies Announces Cultivation Agreement to Establish Company's First Domestic Industrial Hemp Source & Begins Harvesting

AXIMBiotechnologies, Inc. ("AXIM(R) Biotech," "AXIM" or "the Company") (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that it has signed a cultivation agreement...

AXIM : 0.4700 (-0.21%)
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies

SAN DIEGO , Sept. 12, 2019 /PRNewswire/ --  Medical Marijuana, Inc . (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched...

MJNA : 0.0269 (-4.95%)
AXIM : 0.4700 (-0.21%)
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies

Medical Marijuana, Inc. (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

MJNA : 0.0269 (-4.95%)
AXIM : 0.4700 (-0.21%)
AXIM(R) Biotechnologies Featured in Bloomberg Law for Robust Cannabinoid-Based Patent Portfolio

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), a world leader in cannabinoid research and product development, today announced that it has garnered coverage in...

AXIM : 0.4700 (-0.21%)
AXIM(R) Biotechnologies Launches AXIM(R) Wellness Division Focused on Cannabinoid-Based Nutraceutical Products and Announces New Product Pipeline

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), a world leader in cannabinoid research and product development, today announced that it has launched its AXIM(R)...

AXIM : 0.4700 (-0.21%)
AXIM(R) Biotechnologies Receives Seventh Private Label Gum Purchase Order Pushing Orders to Nearly $900,000 for Last Five Months

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), a world leader in cannabinoid research and product development, today announced that the Company has received its...

AXIM : 0.4700 (-0.21%)
AXIM(R) Biotechnologies Signs Licensing Agreement With Leading Gum Distributor to Expand Nutraceutical Division

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), a world leader in cannabinoid research and product development, today announced that the Company has signed a multi-term...

AXIM : 0.4700 (-0.21%)
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

MJNA : 0.0269 (-4.95%)
AXIM : 0.4700 (-0.21%)
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

NEW YORK , June 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA ) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched...

MJNA : 0.0269 (-4.95%)
AXIM : 0.4700 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade AXIM with:

Key Turning Points

2nd Resistance Point 0.5500
1st Resistance Point 0.5100
Last Price 0.4700
1st Support Level 0.4200
2nd Support Level 0.3700

See More

52-Week High 2.5000
Fibonacci 61.8% 1.7016
Fibonacci 50% 1.4550
Fibonacci 38.2% 1.2084
Last Price 0.4700
52-Week Low 0.4100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar